Juan W. Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“The Cholangiocarcinoma Foundation 2026 Career Development Award has been awarded to Dr. Rachel Guest, The University of Edinburgh, for IDH1/2 mutations in liver cell plasticity and cholangiocarcinoma – supported by Paul Sidenblad in memory of Kathleen Sidenblad.
The CCF 2026 Innovation Grant has been awarded to Dr. Shishir Maithel, Northwestern Memorial Hospital, for Phase II, Open-label, Non-randomized, Multi-institutional Study of Optimal Preoperative Therapy for Intrahepatic Cholangiocarcinoma – funded by the Mather Family Foundation.
We are grateful to CCF donors for investing in innovation to equip researchers to improve treatments and change the future. We look forward to following this work and sharing outcomes.”
More posts about Cholangiocarcinoma Foundation.
